Next Generation News and Research

RSS

Scientists illuminate how some antibodies can effectively disable ebolaviruses

Some survivors of ebolavirus outbreaks make antibodies that can broadly neutralize these viruses--and now, scientists at Scripps Research have illuminated how these antibodies can disable the viruses so effectively.

16 Apr 2021

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research.

15 Apr 2021

CUNY SPH announces the New York State Vaccine Education and Adoption Project

In a race to transform the vaccine-hesitant into adopters in New York City and surrounding counties as Covid-19 variants rise, the CUNY Graduate School of Public Health and Health Policy has announced the New York State Vaccine Education and Adoption Project.

15 Apr 2021

New nanothin coating could be used to treat deadly bacterial and fungal infections

Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections.

15 Apr 2021

Experts to discuss advanced cancer cell and gene therapies at Summit 2021

April 29 marks a pivotal moment in cancer research when the world's brightest minds come together to discuss how to translate the success of CAR T-cell therapies for blood cancers into successful cell and gene therapies for the most complex and deadly solid tumor cancers.

15 Apr 2021

Biognosys announces strategic agreement with Siemens Healthineers

Biognosys announces today that it has established a strategic agreement with Siemens Healthineers through its clinical laboratory in Berkeley, California.

From Biognosys 14 Apr 2021

Altering a mosquito's gut genes shows promise to curb malaria

Altering a mosquito's gut genes to make them spread antimalarial genes to the next generation of their species shows promise as an approach to curb malaria, suggests a preliminary study published today in eLife.

13 Apr 2021

Brachytherapy may proceed safely in cervical cancer patients following uterine perforation

A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients following uterine perforation.

13 Apr 2021

Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities

Albumedix Ltd. ('Albumedix'), a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the completed expansion of the company’s commercial-scale manufacturing facility, alongside with the establishment of a new Technology Centre equipped with state-of-the-art laboratories at its UK-based campus in Nottingham.

From Albumedix Ltd. 13 Apr 2021

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

In a recent bioRxiv* preprint, the large team of researchers evaluated a SARS-CoV-2 Spike receptor-binding domain ferritin nanoparticle protein vaccine (RFN) in a nonhuman primate challenge model. This study addresses the need for a next-generation, efficacious vaccine with an increased pan-SARS breadth of coverage.

13 Apr 2021

Study finds correlation between COVID-19 pandemic and six unhealthy eating behaviors

A new probe into the lingering impacts of the COVID-19 pandemic revealed correlations to six unhealthy eating behaviors, according to a study by the University of Minnesota Medical School and School of Public Health.

12 Apr 2021

Researchers work to develop dual antigen COVID-19 vaccine candidate

A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.

12 Apr 2021

More than 100 economies receive life-saving COVID-19 vaccines from COVAX

More than one hundred economies have received life-saving COVID-19 vaccines from COVAX, the global mechanism for equitable access to COVID-19 vaccines. The milestone comes 42 days after the first COVAX doses were shipped and delivered internationally, to Ghana on 24 February 2021.

12 Apr 2021

CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center (ACC) at the University of Pennsylvania.

12 Apr 2021

Broadly neutralizing antibodies show promise in preventing tick-borne encephalitis in mice

Tick-borne encephalitis is a disease just as nasty as it sounds. Once bitten by an infected tick, some people develop flu-like symptoms that resolve quietly but leave behind rampant neurological disease--brain swelling, memory loss, and cognitive decline.

9 Apr 2021

SFU mathematics professor to lead new infectious disease modeling network

Simon Fraser University mathematics professor Caroline Colijn will lead a new, national infectious disease modeling network that will inform decisions related to public health threats and better prepare Canada for future pandemics.

9 Apr 2021

Scientists compare DNA damaging properties of chemicals from vape products and cigarettes

Imperial Brands scientists have utilized Toxys' ToxTracker suite of stem-cell based in-vitro assays, which provide mechanistic insight into the potential DNA damaging properties of chemicals, comparing vape e-liquid samples and their aerosols to combustible cigarette smoke.

9 Apr 2021

Intermountain partners with University of Utah to jointly develop new medical educational program

Intermountain Healthcare is working on a transformative model for the future of healthcare called population health that focuses on keeping people in communities healthy and pre-emptively addressing cause of illnesses, rather than just treating people when they are sick.

9 Apr 2021

New technique can make X-rays more efficient at diagnosing bone and other injuries

A novel way to pinpoint and illuminate bone damage promises to make X-rays more efficient at diagnosing bone and other injuries, Flinders University researchers say.

9 Apr 2021

More new SARS-CoV-2 variants are highly likely

In a recent report posted to the bioRxiv preprint server, researchers from the United Kingdom and Uganda reveal unique protein features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to other representatives of Sarbecoviruses.

8 Apr 2021

Next Generation News and Research

Scientists illuminate how some antibodies can effectively disable ebolaviruses

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

CUNY SPH announces the New York State Vaccine Education and Adoption Project

New nanothin coating could be used to treat deadly bacterial and fungal infections

Experts to discuss advanced cancer cell and gene therapies at Summit 2021

Biognosys announces strategic agreement with Siemens Healthineers

Altering a mosquito's gut genes shows promise to curb malaria

Brachytherapy may proceed safely in cervical cancer patients following uterine perforation

Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Study finds correlation between COVID-19 pandemic and six unhealthy eating behaviors

Researchers work to develop dual antigen COVID-19 vaccine candidate

More than 100 economies receive life-saving COVID-19 vaccines from COVAX

CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

Broadly neutralizing antibodies show promise in preventing tick-borne encephalitis in mice

SFU mathematics professor to lead new infectious disease modeling network

Scientists compare DNA damaging properties of chemicals from vape products and cigarettes

Intermountain partners with University of Utah to jointly develop new medical educational program

New technique can make X-rays more efficient at diagnosing bone and other injuries

More new SARS-CoV-2 variants are highly likely

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News